Table 2.
Treatment indications for patients with psoriatic arthritis and associated comorbidities
| Peripheral arthritis |
Axial arthritis |
Pso | Nail Pso |
Enthesitis | Dactylitis | IBD | Uveitis | |
|---|---|---|---|---|---|---|---|---|
| NSAIDs | ? | |||||||
| MTX | ||||||||
| TNFi | Not ETN | Not ETN | ||||||
| IL-17i | ||||||||
| IL-12i/IL-23i | ||||||||
| IL-23i | ? | |||||||
| JAKi | ? | |||||||
| PDE4i | ||||||||
| CTLA4i | ||||||||
| Integrin inhibitors |
Legend: Green=effective, yellow=moderately effective, gray=ineffective, red=caution. Pso: Psoriasis, CD: Crohn’s disease, ETN: etanercept, IBD: inflammatory bowel disease, NSAIDs: nonsteroidal anti-inflammatory drugs, MTX: methotrexate, TNFi: tumor necrosis alpha inhibitor, IL: interleukin, JAKi: janus kinase inhibitor, PDE4i: Phosphodiesterase-4 inhibitor, CTLA4i: cytotoxic T-lymphocyte antigen 4 inhibitor